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ABSTRACT 
Objective: It is commonly reported that medicines have side effects related to dermatological practice. However, it is extremely difficult to establish 
how commonly, or rarely skin-related medication side effects occur. Common dermatological side effects include rash, pruritus, and 
photosensitivity.  
Objective: To demonstrate the dermatological side-effects of the most commonly prescribed medications in the United Kingdom. 
Methods: This paper discusses dermatological side-effects of the commonly prescribed medications, including uncommon or rare manifestations 
such as angioedema and Stevens - Johnson syndrome (SJS). The list used for the most frequently prescribed drugs in the United Kingdom was 
created by nurses. This list was compared to the British National Formulary to demonstrate the reported frequency of occurrence of dermatological 
side-effects or complications.  
Conclusion: The top 100 prescribed medication cause a number of dermatological side effects that need to be considered when they are prescribed 
to patients who have pre-existing skin conditions. Additionally, when confronted with a common dermatological problem in any patient, clinicians 
should always consider the possibility of a drug adverse reaction. 
Keywords: Drug side effects, Drug-induced stevens-johnson syndrome, Drug-induced licheniform eruptions, Photosensitizing effect, 
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Dermatological adverse reactions are thought to be common, but the 
true incidence remains speculative because the reactions resemble 
commonly occurring skin conditions and the true cause may, 
therefore, be missed. Examples would include excessive sensitivity 
to UV, mainly the ultraviolet spectrum B (UVB, 280–320 nm) 
broadband (UVB-BB, 380-320 nm) present in normal sunlight but 
also used in the treatment of psoriasis [1]. Common medications 
known to cause this reaction include: griseofulvin, sulphonamides, 
sulphonylureas, thiazide diuretics, amiodarone, nalidixic acid, 
tetracyclines and chlorpromazine [2]. Skin presentation may appear 
after weeks or months and appear eczematous, lichenoid, urticarial, 
bullous or may appear as a purpuric eruption.  
Some medications may cause skin tone changes; which may be 
hyper-or hypopigmentation. It may be widespread or localised e. g., 
metabolic disposition in the dermis such as; skin stain after using 
silver dressings or enhanced melanin production with or without an 
increase in melanocytes as occurs with antimalarials, amiodarone, 
NSAIDs, and bleomycin sulphate [3]. 
Others may cause nail changes such as chemotherapy (white, 
depression, and separation from the nail-bed, beau’s lines or 
interruption of normal growth), minocycline (blue-black stain) or 
potassium permanganate (brown stain) [4]. Hair changes can also 
occur; total loss of hair (alopecia) where the drug interferes in the 
anagen (hair growth) phase, partial or complete temporary 
alopecia e. g. cytotoxic drugs (reversible after ceasing treatment, 
dose-dependent, start after short period of drug commencement), 
delay in hair growth (telogen phase or the shedding cycle faster 
than growth cycle), retinoid therapy and danazol therapy 
(Hirsutism/Hypertrichosis in women or change in hair pattern in 
men [5]. 
Some medications, as part of their activity, cause changes to the 
skin’s immune system and may promote skin malignancy; e. g., 
ciclosporin, mycophenolate mofetil, tacrolimus [6]. Drug-induced 
exanthems is a widespread rash, erythema (redness,<90% of body 
surface area), morbilliform or maculopapular in appearance. 
Precipitating medications include; chloroquine, ampicillin and 
isoniazid [7]. Urticarial rash: (hives-red, itchy wheals) and 
angioedema may be caused by penicillin and irritant contact 
dermatitis from a number of medications [8]. 
Pruritus is usually a centrally-mediated reaction; e. g. side effects of 
opioids and tramadol, which cannot be treated by antihistamines 
and is usually resolved only by ceasing the medication [8]. Fixed 
drug eruptions occur where the eruption occurs at the same spot 
every time that the same medication is administered, e. g. dapsone, 
metronidazole or aspirin [9]. 
Acneiform eruptions can be caused by drug-mediated acne 
eruptions, e. g. anabolic steroids. Psoriasiform eruptions present as 
worsening of pre-existing psoriasis, e. g., Lithium and β-blockers. 
Lichenoid eruptions: resolve by ceasing the drug. They appear as flat 
mauve lesions, but they can be scaly and may flow into each other, e. 
g. gold salts, imatinib, interferon-α [10, 11]. Erythema multiforme is 
an eruption of target-like lesions and in severe cases the center 
blisters. Limbs and mucous membranes are involved but not the 
trunk. It typically occurs two weeks after commencing the drug, e. g: 
allopurinol and macrolide antibiotics. The condition is reversible on 
ceasing the medication. Topical corticosteroids can be used for 
limbs, paracetamol for pain and fever and topical treatment can be 
used for oral, ocular and genital symptoms [10, 11]. 
Stevens-Johnson syndrome and toxic epidermal necrolysis 
(SJS/TEN) are the two conditions that may be life-threatening. They 
are mucocutaneous drug hypersensitivity syndromes where 
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blistering and epidermal sloughing occur. SJS causes<10% of body 
surface area skin detachment and TEN causes>10% of body surface 
area skin detachment (e. g., lamotrigine, doxycycline, and co-
trimoxazole). Drug withdrawal and supportive treatments include: 
systemic steroids or ciclosporin, IV immunoglobulin, infection 
management, thermoregulation, maintenance of fluid balance, 
skincare and eye care [10, 11]. 
Drug reaction with eosinophilia and systemic symptoms (DRESS) 
presents as an extensive, inflammatory, maculopapular exanthem 
with lymph node enlargement, abnormal LFTs and haematological 
abnormalities, with raised eosinophil count, or presence of atypical 
lymphocytes. There may also be renal, pulmonary or cardiac 
involvement (e. g., vancomycin, sulfasalazine, antiretrovirals). It can 
be fatal (10%), and has long latency, characteristically 2-8 w from 
drug commencement date [12]. 
Acute generalized exanthematous pustulosisis characterized by 
widespread monomorphic pustules and fever. Patients are generally 
unwell and have excessive heat and fluid loss. This condition can be 
treated by topical potent steroids and can be caused by e. g., 
lamotrigine, metronidazole, and amoxicillin [13]. 
Lupus erythematosus is characterized by seroconversion to being 
antinuclear antibody positive. Patient may recover after drug 
withdrawal but may retain residual antibodies. The skin eruption is 
a butterfly-shaped rash on the face, photosensitive erythema on 
dorsal hands and neck and annular lesions on limbs. It is treated by 
infliximab and etanercept which targets TNF-α [10, 11]. 
Vasculitis occurs characterized by inflammation of the vessel walls 
(lower limbs). Drug withdrawal and systemic steroids or IV 
immunoglobulin can be used in its treatment [14]. 
To demonstrate the skin side-effects of the most commonly 
prescribed medications a list of the top 100 [15] used medications in 
the United Kingdom was identified. The aim of this study was to 
evaluate the frequency of skin complications and side-effects as a 
result of the 100 most commonly prescribed medications in the 
United Kingdom. The dermatology department in New Cross 
Hospital, (Royal Wolverhampton NHS Trust) aimed to establish a list 
of medications to give doctors and patients an idea of what 
medications are capable of producing in the skin as a side-effect. 
MATERIALS AND METHODS 
Method 
The list of the top 100 drugs prescribed in the UK was obtained from 
the Nursing Notes web page (https://nursingnotes.co.uk/the-100-
most-common-medications-in-uk-hospitals/, 13/02/2019, table 1). 
Subsequently, the British National Formulary was used to extract the 
information about the side-effects and was divided and subdivided 
according to reported frequency. The findings were analysed and 
represented as histograms. 
 
Table 1: Top 100 most-prescribed medications in UK hospitals (Source: https://nursingnotes. co. uk/the-100-most-common-medications-
in-uk-hospitals/. Accessed on 13/2/2019) 
Adenosine Clonazepam Heparin Omeprazole 
Alendronic Acid Co-amoxiclav Ibuprofen Ondansetron 
Amiloride Codeine Indapamide Oxycodone 
Amiodarone Cyclizine Insulin Phenobarbitol 
Amitriptyline Diazapam Ipratropium Phenytoin 
Amlodipine Diazepam Ketamine Piperacillin/Tazobactam  
Amoxicillin Diclofenac Lansoprazole Pravastatin 
Apixaban Digoxin Levetiracetam  Prochlorperazine 
Atenolol Dihydrocodeine Levofloxacin Ramipril 
Atenolol Diltiazem Levomepromazine Rivaroxaban 
Atorvastatin Diltiazem Levothyroxine Salbutamol 
Bendroflumethiazide Doxazosin Lisinopril Sertraline 
Bisoprolol Doxycycline Lorazepam Simvastatin 
Bisoprolol Enoxaparin Lorazepam Sodium valproate 
Bumetanide Esomeprazole Losartan Spironolactone 
Candesartan Fentanyl Meropenem Temazepam 
Carbamazepine Flucloxacillin Metformin Theophylline 
Ceftazidime Fluoxetine. Metoclopramide Tiotropium 
Cefuroxime Funderparinex Midazolam Tramadol 
Cephalexin Furosemide Mirtazapine Trazodone 
Chlordiazepoxide Gabapentin Morphine Trimethoprim 
Ciprofloxacin Gabapentin Naproxen Vancomycin 
Citalopram Gentamycin Nefopam Venlafaxine 
Clarithromycin Gliclazide Nifedipine Warfarin 
Clindamycin Haloperidol Nitrofurantoin Zopiclone 
 
RESULTS AND DISCUSSION 
Cutaneous side effects were reported for all 100 most prescribed 
medications, but the frequency varied from rare to very common 
and the severity varied from very mild to very severe. 
Rash, pruritus and urticaria were among the most common side-
effects experienced by patients as a result of being prescribed the 
aforementioned medications (fig. 1). 
Other common side-effects in decreasing order were 
photosensitivity, alopecia, angioedema, SJS, TEN, Jaundice, flushing, 
dermatitis and acne. These side effects were the most often reported 
as being side effects but rash and urticaria were the most common 
skin condition to occur or be present. Adverse drug reactions vary in 
severity and may be localized to the skin or affect multiple organs 
[16]. Hair loss has been associated with the use of 39 out of the 100 
most common medications prescribed. Psychotropic drugs can cause 
hair loss [17] in addition to antidepressants including Selective 
Serotonin Re-uptake Inhibitors (SSRIs) [18]. Alopecia has also been 
shown to be associated with the use of valproate on a dose-
dependent basis [19]. It was noted that upon cessation of the 
medication, hair growth usually spontaneously returns. 
A study conducted in Denmark by the Committee on Adverse Drug 
Reactions concluded that most common side effects of diuretics, 
beta-blocking agents, and anti-hypertensive drugs are 
dermatologically-related [20]. 
Skin side effects associated with mood stabilizers range from simple 
rashes to SJS, TEN and exfoliative dermatitis, [21, 22]as appears to 
be confirmed in this study. 
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Fig. 1: Most common skin side effects in the top prescribed drugs (more than 10 incidences in 100,000) 
 
Antibiotics and anticonvulsants are two common medication groups 
causing skin reactions, including maculopapular rashes, urticaria 
and, in severe cases, SJS, TEN and DRESS [23]. 
It was found that 28 of the 100 most commonly prescribed 
medications cause photosensitivity. The photosensitivity most 
commonly occurs as a phototoxic reaction or less commonly as 
photoallergic reactions and photo-aggravated dermatitis. The most 
common drugs causing photosensitivity are nonsteroidal anti-
inflammatory drugs (NSAIDs), amiodarone, phenothiazines 
(especially chlorpromazine), retinoids, antibiotics (sulfonamides, 
tetracyclines, (especially demeclocycline) and quinolones) [23, 24]. 
SJS and TEN are considered uncommon but serious reactions with 
high morbidity and mortality. The available data is almost entirely 
from case reports and observational series. DRESS syndrome is 
severe and prolonged, affecting multiple organs. To date, no test has 
been recognised to identify which drug might cause any of these 
severe reactions especially in patients taking multiple drugs, but 
when diagnosed, any medication suspected to cause these severe 
conditions should be promptly withdrawn [2]. 
Out of the 100 most commonly prescribed medications, 75% are 
associated with causing a rash or other dermatological reaction. 
From these, 18 out of 75 (24%) are listed as ‘commonly’ or ‘very 
commonly’ occurring (fig. 2). This is a high ratio especially taking 
into account that 38% cause urticaria 10 out of 38 (26%) common 
or very common, among less common symptoms which can come 
under the category of rash/inflammation of the skin like exfoliative 
dermatitis 9%, acne 4% and others. 
 
 
Fig. 2: Common or very common skin side effects in the top prescribed drugs (more than 10 incidences in 100,000) 
 
Angioedema was found in 23% of all medication with 3 out of 23 
(13%) being common or very common can be combined to the 
urticarial fig. of 38% with (26%) being common or very common 
combining the two values 26% and 13% (39%). 
The second category was pruritus affecting 39% of the reported side 
effects being 10 out of 39 (25.6%) is common or very common. This 
is significant for an irritating symptom.  
The third main category was hair loss, which has medical, cosmetic 
and social concerns and was reported with about one-quarter of the 
medications (25%) though none in the BNF reported this to be 
common or very common. 
The fourth category was photosensitivity 28% and flushing 12% and 
with 9 out of the 12 were reported as common or very common. If 
the two fig. are added together, around 40% of the drugs may cause 
either photosensitivity or flushing. 
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Clearly doctors, pharmacists and most important of all patients need 
to be aware and prepared of such possible side effects. The 
International Consensus on drug allergy 25 (Demoly 2014) provides 
some useful insights into how this agenda may be progressed. They 
revisited the mechanisms of allergy and the time-lines of the various 
reactions. From this, they emphasised how crucial the timescale of 
events can be, to correctly attribute a reaction to a causative agent. 
Without an accurate time-line the ability to correctly respond to 
symptoms and arrive at an accurate diagnosis is seriously 
compromised. Removal of a suspected agent(s) and subsequent re-
challenge is possible, but extremely time-consuming and subjects 
the patient to a double dose of symptoms.  
Side effects relating to the skin are common in the 100 most 
prescribed drugs in our hospitals. The public are not aware of how 
common these side effects are and health professionals need to be 
vigilant, and to educate and inform patients on how common these 
side effects are, and to be able to identify them early. Measures are 
required to combat severe reactions such as SJS, TEN and DRESS 
syndrome. Any drug suspected of causing any of these serious 
conditions should be stopped and immediate treatment commenced.  
CONCLUSION  
From this study it is concluded that the best way forward is the 
education of patients and health professionals to be able to move 
forward in interpreting skin reactions:  
1) When confronted with a common dermatological problem in any 
patient, always consider the possibility of a drug adverse reaction. 
2) To be able to progress with such a conclusion, an accurate 
timeline is essential; when was each medication started? Exactly 
when did the reaction first appear? These needs to be identified and 
clearly recorded at the outset, and this information must be included 
in any onward referral. 
3) Accurate record-keeping relating to suspected drug allergies is 
essential; it is insufficient to just record the name of a drug as an 
‘allergy.’ Any record of drug sensitivity must contain brief details of 
what the reaction was; Penicillin–rash; Morphine–hallucinations, at 
the very least. 
4) Reporting suspected drug reactions, even ones believed 
‘common’ to reporting centres will provide more accurate data on 
the frequency of reactions, the extent of the problem and better 
inform public policy. 
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